vialroom

#cagrilintide 2026-03-26

Thursday33 messages7 participantstimes are UTC
Highlights from this day
  • no_chargeback — i was sceptical about monotherapy and after 9 months im still sceptical, just less so 10:06
  • no_chargeback — its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake 10:14
  • bench_notes — the numbers everyone quotes come from the combination, so comparing them to monotherapy logs is unfair, n of 1 obviously 11:03
  • bench_notes — added it to an existing tirzepatide dose rather than starting both, which made attribution possible, we shall see 12:15
RR

CagriSema is cagrilintide with semaglutide and REDEFINE is the trial programme around it

RR

20 in 1ml gives 2mg/ml which is what i use, purely because the units come out round

slower than the others

does the fullness effect fade the way appetite suppression does

AT

you cannot tell which of the two is doing what in a combination and i stopped pretending i could

i was sceptical about monotherapy and after 9 months im still sceptical, just less so

👍10
NC

its an amylin analogue, different receptor family, so treating it as another GLP-1 is the first mistake

how slow are people titrating this compared to cagrilintide

lost 44lb over 18 months on the combination and i genuinely cannot apportion it

BN

the numbers everyone quotes come from the combination, so comparing them to monotherapy logs is unfair, n of 1 obviously

BN

monotherapy question, did appetite move for you without a GLP-1 alongside

ok so is the nausea profile genuinely different or am i imagining it

BN

added it to an existing tirzepatide dose rather than starting both, which made attribution possible, we shall see

noticed something around week 5 on monotherapy, well after i had given up expecting to, from memory

REDEFINE is the trial

A1

monotherapy was underwhelming for me and i say that as someone who wanted it to work

A1

genuine question monotherapy did work for me, just slower and smaller than i expected

BN

i keep the two on separate days so if something goes wrong i have a chance of knowing which

MO

went slower because the first step gave me two rough days and i took that as information

anyone dosing this on a different day to their retatrutide

AA

held at 5 for 5 months on monotherapy before i touched it again

AA

stopped for 23 months and the fullness went within a fortnight of the last dose

MO

the combination is the thing with trial data behind it, monotherapy in here is mostly us guessing

the slower titration in here is community habit as much as anything, the trials had their own schedule